Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,903,309
+$1,952,291 QoQ
Shares Held
43,329
+5.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#883
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $68,623,451 across 12 Drug Manufacturers - General names. ABBV ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437 | $18,515,602 | |
| 2 | JNJ |
Johnson & Johnson
|
69,174 | $17,568,120 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
43,329 | $10,903,309 | |
| 4 | MRK |
Merck & Co., Inc.
|
61,354 | $7,883,989 | |
| 5 | AMGN |
Amgen Inc
|
14,486 | $5,245,670 | |
| 6 | PFE |
Pfizer Inc
|
154,501 | $3,720,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,027 | $1,787,775 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10,109 | $1,277,171 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,903,309 | 43,329 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,951,018 | 41,156 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,716,765 | 42,526 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,876,801 | 42,657 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,057,764 | 43,410 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,936,028 | 42,650 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,195,701 | 46,121 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $9,379,707 | 47,497 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,868,480 | 45,875 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,247,491 | 45,291 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $6,693,154 | 43,190 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $6,332,515 | 42,483 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $6,114,586 | 45,384 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $5,872,625 | 36,849 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,383,229 | 33,310 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $4,394,035 | 32,740 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,046,928 | 32,952 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,437,979 | 33,545 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,495,009 | 33,198 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,631,012 | 33,661 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,766,005 | 33,434 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,517,041 | 32,499 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,376,984 | 12,851 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,139,983 | 13,015 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,559,000 | 15,879 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,022,012 | 13,414 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||